Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, April 4, 2017 at 11:15 am local time (EEST)
Biohit Oyj has received the following notification.
Person subject to the notification requirement | ||
Name: | Euroclone Spa | Legal Person |
Position: | Closely associated person | |
Person discharging managerial responsibilities in issuer | ||
Name: | Aiolfi, Franco | |
Position: | Member of the Board/Deputy member | |
Initial Notification | ||
Reference number: | 74370089ATTSNBXJVT29_20170404092720_6 | |
Issuer | ||
Name: | Biohit Oyj | |
LEI: | 74370089ATTSNBXJVT29 | |
Transaction details | ||
Transaction date: | 2017-03-30 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Disposal | |
Instrument: | Share | |
ISIN: | FI0009005482 | |
Volume: | 1233 | |
Unit price: | 5,57000 Euro | |
Volume: | 680 | |
Unit price: | 5,59000 Euro | |
Volume: | 260 | |
Unit price: | 5,60000 Euro | |
Volume: | 268 | |
Unit price: | 5,59000 Euro | |
Volume: | 398 | |
Unit price: | 5,54000 Euro | |
Volume: | 500 | |
Unit price: | 5,53000 Euro | |
Volume: | 1159 | |
Unit price: | 5,50000 Euro | |
Volume: | 110 | |
Unit price: | 5,50000 Euro | |
Volume: | 110 | |
Unit price: | 5,50000 Euro | |
Volume: | 750 | |
Unit price: | 5,50000 Euro | |
Volume: | 30 | |
Unit price: | 5,50000 Euro | |
Volume: | 1102 | |
Unit price: | 5,50000 Euro | |
Volume: | 3400 | |
Unit price: | 5,50000 Euro | |
Volume: | 1135 | |
Unit price: | 5,50000 Euro | |
Volume: | 1000 | |
Unit price: | 5,50000 Euro | |
Volume: | 2200 | |
Unit price: | 5,50000 Euro | |
Volume: | 35 | |
Unit price: | 5,50000 Euro | |
Volume: | 35 | |
Unit price: | 5,50000 Euro | |
Volume: | 500 | |
Unit price: | 5,50000 Euro | |
Volume: | 251 | |
Unit price: | 5,50000 Euro | |
Volume: | 36 | |
Unit price: | 5,50000 Euro | |
Volume: | 4389 | |
Unit price: | 5,50000 Euro | |
Volume: | 419 | |
Unit price: | 5,50000 Euro | |
Aggregated transactions | ||
Volume: | 20000 | |
Volume weighted average price: | 5.51143 Euro | |
Transaction details | ||
Transaction date: | 2017-03-31 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Disposal | |
Instrument: | Share | |
ISIN: | FI0009005482 | |
Volume: | 28 | |
Unit price: | 5,51000 Euro | |
Volume: | 80 | |
Unit price: | 5,51000 Euro | |
Volume: | 11 | |
Unit price: | 5,51000 Euro | |
Volume: | 100 | |
Unit price: | 5,50000 Euro | |
Volume: | 26 | |
Unit price: | 5,51000 Euro | |
Volume: | 1262 | |
Unit price: | 5,50000 Euro | |
Volume: | 300 | |
Unit price: | 5,50000 Euro | |
Volume: | 71 | |
Unit price: | 5,50000 Euro | |
Volume: | 926 | |
Unit price: | 5,50000 Euro | |
Volume: | 1 | |
Unit price: | 5,50000 Euro | |
Aggregated transactions | ||
Volume: | 2805 | |
Volume weighted average price: | 5.50052 Euro | |
Transaction details | ||
Transaction date: | 2017-04-03 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Disposal | |
Instrument: | Share | |
ISIN: | FI0009005482 | |
Volume: | 452 | |
Unit price: | 5,50000 Euro | |
Aggregated transactions | ||
Volume: | 452 | |
Volume weighted average price: | 5.50000 Euro |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com